Monday, April 20, 2020 5:56:08 PM
Looks like we're onto something with the institutional buying. Looks like Acorn Financial bought 250k in the first quarter. https://fintel.io/so/us/ntrp
I looked on their website and noticed this section in particular.
"Business
Sales & Mergers
Acorn Financial is uniquely positioned to help assist and advise business owners in evaluating the sale of a business or the prospects of a successful merger. Our Advisors have diverse educational and professional backgrounds that qualify them to work closely alongside top legal professionals to analyze, structure, and complete the sale or merger of your business"
https://acorn-financial.com/services-offered/
I still can't help but wonder if we eventually join up with Bryologyx. There was a blockbuster study published by Nature today detailing progress in synthetic bryostatin especially regarding CAR T cancer treatments. https://www.nature.com/articles/s41467-020-15742-7
BryX would own that IP yet Alkon is working with the NCI on the pediatric cancer study. BryX also picked up the autoimmune conditions IP that includes the incredible Crohn's study from last summer. Plus their co founder started Neurotrope. Wishful thinking maybe, but moving forward would open multiple opportunities as we await further AD developments Imo.
I looked on their website and noticed this section in particular.
"Business
Sales & Mergers
Acorn Financial is uniquely positioned to help assist and advise business owners in evaluating the sale of a business or the prospects of a successful merger. Our Advisors have diverse educational and professional backgrounds that qualify them to work closely alongside top legal professionals to analyze, structure, and complete the sale or merger of your business"
https://acorn-financial.com/services-offered/
I still can't help but wonder if we eventually join up with Bryologyx. There was a blockbuster study published by Nature today detailing progress in synthetic bryostatin especially regarding CAR T cancer treatments. https://www.nature.com/articles/s41467-020-15742-7
BryX would own that IP yet Alkon is working with the NCI on the pediatric cancer study. BryX also picked up the autoimmune conditions IP that includes the incredible Crohn's study from last summer. Plus their co founder started Neurotrope. Wishful thinking maybe, but moving forward would open multiple opportunities as we await further AD developments Imo.
Recent TAOX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:02:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:01:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 08:01:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 09:21:40 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/02/2026 09:32:45 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/02/2026 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 09:23:07 PM
- TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation • PR Newswire (US) • 11/18/2025 02:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/12/2025 09:10:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/07/2025 09:41:16 PM
- TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds • PR Newswire (US) • 11/04/2025 02:15:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 10/24/2025 08:12:47 PM
- TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency • PR Newswire (US) • 10/20/2025 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2025 09:13:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 10:12:21 AM
- TAO Synergies Announces $11 Million Private Placement • PR Newswire (US) • 10/13/2025 09:09:00 PM
- TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO) • PR Newswire (US) • 09/22/2025 01:15:00 PM
- TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event • PR Newswire (US) • 09/08/2025 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 09:00:44 PM
- TAO Synergies Welcomes Top Bittensor (TAO) Leader as Advisor for AI-Focused Crypto Treasury Strategy • PR Newswire (US) • 08/26/2025 01:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/14/2025 08:51:57 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/14/2025 08:50:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 08:19:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 09:17:38 PM
